Dharmaj Crop Guard Limited (DHARMAJ)
Investor Presentation
AI summary
- Q1FY27 revenue grew 5% y-y to ₹3,841 Mn; EBITDA margin improved to 15% from 14% in Q1FY26
- Domestic Branded Formulations flat y-y with improved product mix aiding profitability in Q1FY27
- Export Institutional segment surged 116% y-y, continuing FY26 recovery trend
- Active Ingredients revenue declined 14% y-y due to West Asia crisis and market headwinds
- New Herbicides facility at Kerala GIDC on track to support growth and capacity release
- Management reaffirms annual growth target based on branded, active ingredients scale-up, and export resurgence
- Retail touchpoints increased to 19.5K+ with 21 new sales team members added
- 47 technical and 125 export market product registrations received cumulatively
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 DHARMAJ — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add DHARMAJ to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Dharmaj Crop Guard Limited
Important.
The summary above is generated automatically from Dharmaj Crop Guard Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.